Han, Chun-Jie <br/><br/>
Rosiglitazone inhibits angiotensin II-induced C-reactive protein production in human aortic endothelial cells through regulating AT(1)-ROS-MAPK signal pathway.  [electronic resource] 

 -  Inflammation research : official journal of the European Histamine Research Society ... [et al.]  Sep 2012 
 - 1031-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1420-908X 
<br/><br/><label>Standard No.: </label>10.1007/s00011-012-0496-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin I--metabolism<br/>Angiotensin II--metabolism<br/>Anti-Inflammatory Agents--pharmacology<br/>Aorta--cytology<br/>C-Reactive Protein--genetics<br/>Cells, Cultured<br/>Endothelial Cells--drug effects<br/>Humans<br/>Mitogen-Activated Protein Kinases--metabolism<br/>PPAR gamma--agonists<br/>RNA, Messenger--metabolism<br/>Reactive Oxygen Species--metabolism<br/>Rosiglitazone<br/>Thiazolidinediones--pharmacology